Most Active Articles 2013-05-23T02:57:40.927-04:00 Business Exchange Business_Exchange@businessweek.com urn:com:businessweek:bx:topic:most-active:glaxosmithkline-plc Ulli Muenker umuenker333 urn:com:businessweek:bx:article:6650089882608422248-1de1080a9092ac306de44c8b17a03b3f 2012-07-25T19:35:44.903-04:00

Britain's biggest pharmaceutical company pledges overhaul after landing record £1.9bn fine in US

Britain's biggest pharmaceutical company pledges overhaul after landing record £1.9bn fine in US http://www.guardian.co.uk/business/2012/jul/25/glaxosmithkline-chief-apologises-mis-selling Tea Tree ttree910 2 2 0 0 urn:com:businessweek:bx:article:11386472370810543656-728b1f67fa1b2a50716f27c867f5a5fd 2012-07-02T19:45:08.888-04:00

GlaxoSmithKline will plead guilty to promoting two drugs for unapproved uses and to failing to report important safety data about a diabetes drug.

GlaxoSmithKline will plead guilty to promoting two drugs for unapproved uses and to failing to report important safety data about a diabetes drug. http://www.nytimes.com/2012/07/03/business/glaxosmithkline-agrees-to-pay-3-billion-in-fraud-settlement.html Tea Tree ttree910 2 2 0 0 urn:com:businessweek:bx:article:2669752956889582825-59b3f1ce6004d2b7ef532978ee0fc668 2012-07-04T12:56:05.506-04:00

Four former GlaxoSmithKline employees will share up to $250m (£159m) after their evidence helped US authorities secure a record settlement with the UK drug company for mispromoting drugs

Four former GlaxoSmithKline employees will share up to $250m (£159m) after their evidence helped US authorities secure a record settlement with the UK drug company for mispromoting drugs http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/9374104/Glaxo-whistleblowers-to-share-250m-windfall.html Tea Tree ttree910 2 2 0 0 urn:com:businessweek:bx:article:9831136283936388861-dbbfbb84f96b4a990145e24fe5a31d8d 2013-02-06T16:29:28.129-05:00

GlaxoSmithKline plans to cut costs in its struggling European drugs division and promised investors a return to growth this year, after failing to deliver a hoped-for sales and margin recovery in 2012.

GlaxoSmithKline plans to cut costs in its struggling European drugs division and promised investors a return to growth this year, after failing to deliver a hoped-for sales and margin recovery in 2012. http://www.nytimes.com/reuters/2013/02/06/business/06reuters-glaxosmithkline-earnings.html Tea Tree ttree910 4 4 0 0 urn:com:businessweek:bx:article:13473907176017185274-d6b70530635c67ec652376b880da8191 2012-03-12T20:58:00.451-04:00

GlaxoSmithKline's chief executive saw his earnings almost double last year as total shareholder returns at Britain's biggest drug maker hit their highest level since the creation of the company

GlaxoSmithKline's chief executive saw his earnings almost double last year as total shareholder returns at Britain's biggest drug maker hit their highest level since the creation of the company http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/9139344/GlaxoSmithKline-boss-pay-packet-near-doubles.html Tea Tree ttree910 3 3 0 0 urn:com:businessweek:bx:article:14429506699269947381-be529e4f2320513476ecea0179f09008 2009-05-21T22:48:00.000-04:00

is about EUR2.5 billion. As Sanofi isn't active in Qiagen's main business area, rivals like GlaxoSmithKline PLC (GSK) would seem better positioned for such an acquisition, he added. At 1113 GMT, shares in Qiagen, which provides sample and assay

is about EUR2.5 billion. As Sanofi isn't active in Qiagen's main business area, rivals like GlaxoSmithKline PLC (GSK) would seem better positioned for such an acquisition, he added. At 1113 GMT, shares in Qiagen, which provides sample and assay http://c.moreover.com/click/here.pl?r1993019920&f=9791 46 46 0 0 urn:com:businessweek:bx:article:7241728625586875527-ad3efc26dd52ba414b4b537d7fcef966 2011-05-25T23:31:00.000-04:00

Ho, a medical doctor, graduated from Yale University before working in cancer-drug development at Johnson & Johnson and GlaxoSmithKline Plc. Chief Scientific Officer Pearl Huang has a PhD in molecular biology from Princeton University and led research

Ho, a medical doctor, graduated from Yale University before working in cancer-drug development at Johnson & Johnson and GlaxoSmithKline Plc. Chief Scientific Officer Pearl Huang has a PhD in molecular biology from Princeton University and led research http://c.moreover.com/click/here.pl?r4674009250&f=9791 8 7 1 0 urn:com:businessweek:bx:article:3998533890901620945-861f17e5f3f40c214ea30ade8d362027 2009-02-22T01:43:00.000-05:00

China for 15 years, part of that time as a sales manager for pharmaceutical maker SmithKline Beecham, now GlaxoSmithKline PLC (GSK ). He founded BabyCare to exploit what he saw as a big potential market in China for nutritional supplements for expectant

China for 15 years, part of that time as a sales manager for pharmaceutical maker SmithKline Beecham, now GlaxoSmithKline PLC (GSK ). He founded BabyCare to exploit what he saw as a big potential market in China for nutritional supplements for expectant http://c.moreover.com/click/here.pl?r1833186250&f=9791 68 68 0 0 urn:com:businessweek:bx:article:2632886544279918036-9be83e36caac2e81e50c57e417f76dcf 2009-03-28T16:34:00.000-04:00

Anybody else heard this rumor about some type of deal?

Anybody else heard this rumor about some type of deal? http://www.cafepharma.com/boards/showthread.php?t=367111 20 20 0 0 urn:com:businessweek:bx:article:14436714061599143096-20a9c8b0ea090b38e8c2af686132c86f 2009-03-24T04:15:00.000-04:00

Allergan Inc. soared in afternoon action Tuesday as rumors circulated on Wall Street that U.K. pharmaceutical giant GlaxoSmithKline PLC could be considering a bid for the company. Shares of Allergan (AGN:AGNNews , chart , profile , more Last: Delayed

Allergan Inc. soared in afternoon action Tuesday as rumors circulated on Wall Street that U.K. pharmaceutical giant GlaxoSmithKline PLC could be considering a bid for the company. Shares of Allergan (AGN:AGNNews , chart , profile , more Last: Delayed http://c.moreover.com/click/here.pl?r1885290870&f=9791 12 12 0 0 urn:com:businessweek:bx:article:494783366952340355-f9bcc397edec208e570e277b8d7b2979 2009-10-27T22:08:00.000-04:00

Strong growth in emerging markets and Japan, and in consumer healthcare products, offset declines in US pharmaceuticals, GlaxoSmithKline said on Wednesday, as the UK-based drugs group expects strong sales of flu vaccine in the coming months. “The

Strong growth in emerging markets and Japan, and in consumer healthcare products, offset declines in US pharmaceuticals, GlaxoSmithKline said on Wednesday, as the UK-based drugs group expects strong sales of flu vaccine in the coming months. “The http://c.moreover.com/click/here.pl?r2295186574&f=9791 35 35 0 0 urn:com:businessweek:bx:article:9389987128586786976-d8d16db43265277b898ced598bc21ff3 2009-10-09T09:05:23.902-04:00

WSJ.com is available in the following editions and languages:

WSJ.com is available in the following editions and languages: http://online.wsj.com/article/SB125503764592374389.html Andrea Muller amuller078 10 9 1 0 urn:com:businessweek:bx:article:13998385267905520615-f696d69214febec01ce9ce82ebbc7694 2009-02-02T23:19:00.000-05:00

$1.4 billion to $1.6 billion previously. Gardasil, which is facing competition from a rival product from GlaxoSmithKline PLC, was recently denied approval by U.S. regulators for use by women aged 27 to 45. Merck said its 2009 sales would be at the lower

$1.4 billion to $1.6 billion previously. Gardasil, which is facing competition from a rival product from GlaxoSmithKline PLC, was recently denied approval by U.S. regulators for use by women aged 27 to 45. Merck said its 2009 sales would be at the lower http://c.moreover.com/click/here.pl?r1802267470&f=9791 8 7 1 0 urn:com:businessweek:bx:article:17320853255485577149-d5699ef44157dda37333ffd1eaacdeab 2009-06-08T10:29:44.091-04:00

TBWA's win last week of $170 million of the GlaxoSmithKline Consumer Healthcare business comes with what a lot of agencies would consider an unpleasant side effect: the chore of marketing a weight-loss drug that can result in...

TBWA's win last week of $170 million of the GlaxoSmithKline Consumer Healthcare business comes with what a lot of agencies would consider an unpleasant side effect: the chore of marketing a weight-loss drug that can result in... http://adage.com/agencynews/article?article_id=137127 Leslie MacCallum lmaccallum946 15 14 0 1 urn:com:businessweek:bx:article:14565184954040577890-f28840bdf61d476b73f59939aebe2b43 2010-05-26T11:16:38.575-04:00

GlaxoSmithKline is applying open-source principles in an effort to help find a drug for malaria, providing to the public the designs behind 13,500 chemical compounds and seeking input from outsiders.

GlaxoSmithKline is applying open-source principles in an effort to help find a drug for malaria, providing to the public the designs behind 13,500 chemical compounds and seeking input from outsiders. http://online.wsj.com/article/SB10001424052748703341904575266583403844888.html Terri Griffith tgriffith986 3 3 0 0 urn:com:businessweek:bx:article:3572333044570919142-0f3677b66fd01ca3c0e8dab37323d822 2009-09-25T15:17:15.508-04:00

Pharma giant GlaxoSmithKline plc (NYSE:GSK) has done a dozen or so acquisitions and partnerships since Andrew Witty took over as CEO in May of 2008, and it would like to do more. But GSK R&D chief Moncef Slaoui (pictured) complains in an interview with Bloomberg published Friday that "desperate" rivals have are bidding the prices up too high.

Pharma giant GlaxoSmithKline plc (NYSE:GSK) has done a dozen or so acquisitions and partnerships since Andrew Witty took over as CEO in May of 2008, and it would like to do more. But GSK R&D chief Moncef Slaoui (pictured) complains in an interview with Bloomberg published Friday that "desperate" rivals have are bidding the prices up too high. http://www.thedeal.com/corporatedealmaker/2009/09/drug_deals_too_pricey_says_gsk.php Halja Likakik bwysong598 6 6 0 0 urn:com:businessweek:bx:article:12517874193019731885-f90b56500b9f7af38151b9e86bdb81a0 2009-10-07T03:02:01.889-04:00

* JV will make child vaccines for use in China * Glaxo to get 65 pct equity, Walvax to get 35 pct * Is part of Glaxo's strategy to expand in emerging markets (Adds details) LONDON, Oct 6 (Reuters) - Britain's GlaxoSmithKline (GSK.L) said on Tuesday...

* JV will make child vaccines for use in China * Glaxo to get 65 pct equity, Walvax to get 35 pct * Is part of Glaxo's strategy to expand in emerging markets (Adds details) LONDON, Oct 6 (Reuters) - Britain's GlaxoSmithKline (GSK.L) said on Tuesday... http://www.reuters.com/article/rbssHealthcareNews/idUSL624654920091006 Bruce Einhorn beinhorn468 5 5 0 0 urn:com:businessweek:bx:article:18108661287583947995-4fc634acd520b76c7a2df7ea951c88ba 2010-01-05T09:20:35.740-05:00

GlaxoSmithKline slips after France cuts back on swine flu vaccine

GlaxoSmithKline slips after France cuts back on swine flu vaccine http://xhotgossipx.blogspot.com/2010/01/glaxosmithkline-slips.html Tracy Collins tcollins888 5 5 0 0 urn:com:businessweek:bx:article:1125847304249168810-13c78491775df4ba1327ad895c806511 2009-02-17T18:51:41.544-05:00

The world's second biggest pharmaceutical company is to radically shift its attitude to providing cheap drugs to millions of people in the developing world. In a major change of strategy, the new head of GlaxoSmithKline, Andrew Witty, has told the...

The world's second biggest pharmaceutical company is to radically shift its attitude to providing cheap drugs to millions of people in the developing world. In a major change of strategy, the new head of GlaxoSmithKline, Andrew Witty, has told the... http://www.guardian.co.uk/business/2009/feb/13/glaxo-smith-kline-cheap-medicine Ulli Muenker umuenker333 5 5 0 0 urn:com:businessweek:bx:article:3543855963434930147-2ad7b3ee1a9bc551ffa2f60e8aa56315 2009-07-13T15:21:05.329-04:00

- GlaxoSmithKline Plc’s diabetes drug Avandia failed to benefit patients with Alzheimer’s disease, according to a company-funded study. The findings are another setback for Avandia, once the...

- GlaxoSmithKline Plc’s diabetes drug Avandia failed to benefit patients with Alzheimer’s disease, according to a company-funded study. The findings are another setback for Avandia, once the... http://www.bloomberg.com/apps/news?pid=20601202&sid=awMBwVDgfi0U Cathy Arnst carnst812 4 3 0 1 urn:com:businessweek:bx:article:12964197925333093902-aa30f02a06644829a7524f87b4fc2e86 2009-03-24T22:41:00.000-04:00

GlaxoSmithKline, the UK-based pharmaceutical group previously accused of concealing sensitive information about its medicines, has promised to make public the findings and details of all clinical trials within 18 months of

GlaxoSmithKline, the UK-based pharmaceutical group previously accused of concealing sensitive information about its medicines, has promised to make public the findings and details of all clinical trials within 18 months of http://c.moreover.com/click/here.pl?r1885839114&f=9791 6 6 0 0 urn:com:businessweek:bx:article:17460054015384444106-a17441f9404440ec1dfeaed74d61ac6c 2009-03-24T02:20:00.000-04:00

- Shares of Allergan Inc (AGN.N) jumped more than 16 percent on Tuesday amid market chatter that GlaxoSmithKline Plc (GSK.L) might be interested in acquiring the maker of Botox anti-wrinkle treatment. Glaxo declined to comment on rumors that it might bid

- Shares of Allergan Inc (AGN.N) jumped more than 16 percent on Tuesday amid market chatter that GlaxoSmithKline Plc (GSK.L) might be interested in acquiring the maker of Botox anti-wrinkle treatment. Glaxo declined to comment on rumors that it might bid http://c.moreover.com/click/here.pl?r1885096656&f=9791 6 6 0 0 urn:com:businessweek:bx:article:17679654146406324755-79a984d518b70805ca6e61a8d2baa6e3 2009-09-02T09:38:28.975-04:00

Think you have the flu? In some places, you can now go directly to the Internet and report your symptoms to officials eager to spot outbreaks. Say you feel sick, but before you see a doctor you search the Web for information, or blog or Twitter about the flu. Your worries will be detected by companies prowling the Internet for disease trends. If you actually come down with the flu, and the doctors want to know who you've been in physical contact with, your trusty cellphone could soon tell them, reports Michael Ruane.

Think you have the flu? In some places, you can now go directly to the Internet and report your symptoms to officials eager to spot outbreaks. Say you feel sick, but before you see a doctor you search the Web for information, or blog or Twitter about the flu. Your worries will be detected by companies prowling the Internet for disease trends. If you actually come down with the flu, and the doctors want to know who you've been in physical contact with, your trusty cellphone could soon tell them, reports Michael Ruane. http://www.washingtonpost.com/wp-dyn/content/article/2009/09/01/AR2009090103809.html?hpid=topnews Lauren Young lyoung404 1 0 0 1 urn:com:businessweek:bx:article:16399240534091005167-f2bf787b81f94d343cd7790ea35d9f13 2009-09-01T15:57:09.683-04:00

Okay, I admit it. I’ve been on summer vacation from Swine Flu, which means I’ve given the H1N1 virus little thought. But did someone declare today National Swine Flu Day?

Okay, I admit it. I’ve been on summer vacation from Swine Flu, which means I’ve given the H1N1 virus little thought. But did someone declare today National Swine Flu Day? http://www.businessweek.com/careers/workingparents/blog/archives/2009/09/back_to_school_3.html Lauren Young lyoung404 1 0 0 1 urn:com:businessweek:bx:article:7358044047334175286-4aa0850aec5da3d40c1b2138a19d0d70 2009-02-13T02:36:00.000-05:00

By Lisa Richwine WASHINGTON, Feb 13 (Reuters) - GlaxoSmithKline Plc's (GSK.L Glaxo CEO Andrew Witty said on Friday his company would contribute its own patents for technologies that might aid research into malaria, cholera and more than

By Lisa Richwine WASHINGTON, Feb 13 (Reuters) - GlaxoSmithKline Plc's (GSK.L Glaxo CEO Andrew Witty said on Friday his company would contribute its own patents for technologies that might aid research into malaria, cholera and more than http://c.moreover.com/click/here.pl?r1819981412&f=9791 7 6 1 0